Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C30H44O9 |
Molecular Weight | 548.665 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 12 / 12 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]1(C[C@H](OC)[C@H](O)[C@@H](C)O1)O[C@H]2CC[C@]3(C=O)[C@@]4([H])CC[C@]5(C)[C@H](CC[C@]5(O)[C@]4([H])CC[C@]3(O)C2)C6=CC(=O)OC6
InChI
InChIKey=XQCGNURMLWFQJR-ZNDDOCHDSA-N
InChI=1S/C30H44O9/c1-17-26(33)23(36-3)13-25(38-17)39-19-4-9-28(16-31)21-5-8-27(2)20(18-12-24(32)37-15-18)7-11-30(27,35)22(21)6-10-29(28,34)14-19/h12,16-17,19-23,25-26,33-35H,4-11,13-15H2,1-3H3/t17-,19+,20-,21+,22-,23+,25+,26-,27-,28+,29+,30+/m1/s1
Molecular Formula | C30H44O9 |
Molecular Weight | 548.665 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 12 / 12 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/3821940
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3821940
Cymarin (or cymarine or k-strophanthidin-alpha) is a cardiac glycoside and an anti-arrhythmia and cardiotonic agent. Cymarin works as an inhibitor of Na+ /K+-ATPase . This inhibition has an inotropic effect on the cardiac muscles increasing their force by approximately 100%.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2095186 Sources: https://www.ncbi.nlm.nih.gov/pubmed/6146536 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3821940
Unknown
Route of Administration:
Other
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 18:50:35 GMT 2023
by
admin
on
Fri Dec 15 18:50:35 GMT 2023
|
Record UNII |
UK3LS8435E
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
C01AC03
Created by
admin on Fri Dec 15 18:50:35 GMT 2023 , Edited by admin on Fri Dec 15 18:50:35 GMT 2023
|
||
|
WHO-VATC |
QC01AC03
Created by
admin on Fri Dec 15 18:50:35 GMT 2023 , Edited by admin on Fri Dec 15 18:50:35 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
D003529
Created by
admin on Fri Dec 15 18:50:35 GMT 2023 , Edited by admin on Fri Dec 15 18:50:35 GMT 2023
|
PRIMARY | |||
|
208-087-9
Created by
admin on Fri Dec 15 18:50:35 GMT 2023 , Edited by admin on Fri Dec 15 18:50:35 GMT 2023
|
PRIMARY | |||
|
DB13240
Created by
admin on Fri Dec 15 18:50:35 GMT 2023 , Edited by admin on Fri Dec 15 18:50:35 GMT 2023
|
PRIMARY | |||
|
DTXSID20871714
Created by
admin on Fri Dec 15 18:50:35 GMT 2023 , Edited by admin on Fri Dec 15 18:50:35 GMT 2023
|
PRIMARY | |||
|
m4028
Created by
admin on Fri Dec 15 18:50:35 GMT 2023 , Edited by admin on Fri Dec 15 18:50:35 GMT 2023
|
PRIMARY | Merck Index | ||
|
508-77-0
Created by
admin on Fri Dec 15 18:50:35 GMT 2023 , Edited by admin on Fri Dec 15 18:50:35 GMT 2023
|
PRIMARY | |||
|
CYMARIN
Created by
admin on Fri Dec 15 18:50:35 GMT 2023 , Edited by admin on Fri Dec 15 18:50:35 GMT 2023
|
PRIMARY | |||
|
CHEMBL1651908
Created by
admin on Fri Dec 15 18:50:35 GMT 2023 , Edited by admin on Fri Dec 15 18:50:35 GMT 2023
|
PRIMARY | |||
|
7522
Created by
admin on Fri Dec 15 18:50:35 GMT 2023 , Edited by admin on Fri Dec 15 18:50:35 GMT 2023
|
PRIMARY | |||
|
441853
Created by
admin on Fri Dec 15 18:50:35 GMT 2023 , Edited by admin on Fri Dec 15 18:50:35 GMT 2023
|
PRIMARY | |||
|
UK3LS8435E
Created by
admin on Fri Dec 15 18:50:35 GMT 2023 , Edited by admin on Fri Dec 15 18:50:35 GMT 2023
|
PRIMARY | |||
|
4408
Created by
admin on Fri Dec 15 18:50:35 GMT 2023 , Edited by admin on Fri Dec 15 18:50:35 GMT 2023
|
PRIMARY |